Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Combinatorial pathway disruption is a powerful approach to delineate metabolic impacts of endocrine disruptors

K. Bernal, C. Touma, C. Erradhouani, T. Boronat-Belda, L. Gaillard, S. Al Kassir, H. Le Mentec, C. Martin-Chouly, N. Podechard, D. Lagadic-Gossmann, S. Langouet, F. Brion, A. Knoll-Gellida, PJ. Babin, I. Sovadinova, P. Babica, K. Andreau, R....

. 2022 ; 596 (24) : 3107-3123. [pub] 20220822

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, přehledy, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22032475

The prevalence of metabolic diseases, such as obesity, diabetes, metabolic syndrome and chronic liver diseases among others, has been rising for several years. Epidemiology and mechanistic (in vivo, in vitro and in silico) toxicology have recently provided compelling evidence implicating the chemical environment in the pathogenesis of these diseases. In this review, we will describe the biological processes that contribute to the development of metabolic diseases targeted by metabolic disruptors, and will propose an integrated pathophysiological vision of their effects on several organs. With regard to these pathomechanisms, we will discuss the needs, and the stakes of evolving the testing and assessment of endocrine disruptors to improve the prevention and management of metabolic diseases that have become a global epidemic since the end of last century.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22032475
003      
CZ-PrNML
005      
20230131151506.0
007      
ta
008      
230120s2022 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1002/1873-3468.14465 $2 doi
035    __
$a (PubMed)35957500
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Bernal, Kévin $u INSERM UMR-S 1124, Paris, France $u Université Paris Cité, France
245    10
$a Combinatorial pathway disruption is a powerful approach to delineate metabolic impacts of endocrine disruptors / $c K. Bernal, C. Touma, C. Erradhouani, T. Boronat-Belda, L. Gaillard, S. Al Kassir, H. Le Mentec, C. Martin-Chouly, N. Podechard, D. Lagadic-Gossmann, S. Langouet, F. Brion, A. Knoll-Gellida, PJ. Babin, I. Sovadinova, P. Babica, K. Andreau, R. Barouki, J. Vondracek, P. Alonso-Magdalena, E. Blanc, MJ. Kim, X. Coumoul
520    9_
$a The prevalence of metabolic diseases, such as obesity, diabetes, metabolic syndrome and chronic liver diseases among others, has been rising for several years. Epidemiology and mechanistic (in vivo, in vitro and in silico) toxicology have recently provided compelling evidence implicating the chemical environment in the pathogenesis of these diseases. In this review, we will describe the biological processes that contribute to the development of metabolic diseases targeted by metabolic disruptors, and will propose an integrated pathophysiological vision of their effects on several organs. With regard to these pathomechanisms, we will discuss the needs, and the stakes of evolving the testing and assessment of endocrine disruptors to improve the prevention and management of metabolic diseases that have become a global epidemic since the end of last century.
650    _2
$a lidé $7 D006801
650    12
$a endokrinní disruptory $x toxicita $7 D052244
650    12
$a metabolický syndrom $7 D024821
650    _2
$a obezita $x chemicky indukované $7 D009765
650    _2
$a fenoly $7 D010636
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Touma, Charbel $u Inserm, EHESP, Irset (Institut de recherche en santé environnement et travail) - UMR_S 1085, Université Rennes, France
700    1_
$a Erradhouani, Chedi $u Université Paris Cité, France $u Ecotoxicologie des substances et des milieux, Parc ALATA, INERIS, Verneuil-en-Halatte, France
700    1_
$a Boronat-Belda, Talía $u Instituto de Investigación, Desarrollo e Innovación en Biotecnología Sanitaria de Elche (IDiBE), Universitas Miguel Hernández, Elche, Spain $u Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Madrid, Spain
700    1_
$a Gaillard, Lucas $u INSERM UMR-S 1124, Paris, France $u Université Paris Cité, France
700    1_
$a Al Kassir, Sara $u Department of Life and Health Sciences, INSERM U1211, MRGM, University of Bordeaux, Pessac, France
700    1_
$a Le Mentec, Hélène $u Inserm, EHESP, Irset (Institut de recherche en santé environnement et travail) - UMR_S 1085, Université Rennes, France
700    1_
$a Martin-Chouly, Corinne $u Inserm, EHESP, Irset (Institut de recherche en santé environnement et travail) - UMR_S 1085, Université Rennes, France
700    1_
$a Podechard, Normand $u Inserm, EHESP, Irset (Institut de recherche en santé environnement et travail) - UMR_S 1085, Université Rennes, France
700    1_
$a Lagadic-Gossmann, Dominique $u Inserm, EHESP, Irset (Institut de recherche en santé environnement et travail) - UMR_S 1085, Université Rennes, France
700    1_
$a Langouet, Sophie $u Inserm, EHESP, Irset (Institut de recherche en santé environnement et travail) - UMR_S 1085, Université Rennes, France
700    1_
$a Brion, François $u Ecotoxicologie des substances et des milieux, Parc ALATA, INERIS, Verneuil-en-Halatte, France
700    1_
$a Knoll-Gellida, Anja $u Department of Life and Health Sciences, INSERM U1211, MRGM, University of Bordeaux, Pessac, France
700    1_
$a Babin, Patrick J $u Department of Life and Health Sciences, INSERM U1211, MRGM, University of Bordeaux, Pessac, France
700    1_
$a Sovadinova, Iva $u RECETOX, Faculty of Science, Masaryk University, Brno, Czech Republic
700    1_
$a Babica, Pavel $u RECETOX, Faculty of Science, Masaryk University, Brno, Czech Republic
700    1_
$a Andreau, Karine $u INSERM UMR-S 1124, Paris, France $u Université Paris Cité, France
700    1_
$a Barouki, Robert $u INSERM UMR-S 1124, Paris, France $u Université Paris Cité, France $1 https://orcid.org/000000019471399X
700    1_
$a Vondracek, Jan $u Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic
700    1_
$a Alonso-Magdalena, Paloma $u Instituto de Investigación, Desarrollo e Innovación en Biotecnología Sanitaria de Elche (IDiBE), Universitas Miguel Hernández, Elche, Spain $u Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Madrid, Spain
700    1_
$a Blanc, Etienne $u INSERM UMR-S 1124, Paris, France $u Université Paris Cité, France
700    1_
$a Kim, Min Ji $u INSERM UMR-S 1124, Paris, France $u Université Sorbonne Paris Nord, Bobigny, France
700    1_
$a Coumoul, Xavier $u INSERM UMR-S 1124, Paris, France $u Université Paris Cité, France
773    0_
$w MED00001785 $t FEBS letters $x 1873-3468 $g Roč. 596, č. 24 (2022), s. 3107-3123
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35957500 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230120 $b ABA008
991    __
$a 20230131151502 $b ABA008
999    __
$a ok $b bmc $g 1891311 $s 1183810
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2022 $b 596 $c 24 $d 3107-3123 $e 20220822 $i 1873-3468 $m FEBS letters $n FEBS Lett $x MED00001785
LZP    __
$a Pubmed-20230120

Najít záznam

Citační ukazatele

Možnosti archivace